IRIS Accounts Production v26.2.0.496 SC191254 Board of Directors Board of Directors 1.3.24 28.8.25 28.8.25 false true false false false true false Fair value model Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC1912542024-02-29SC1912542025-08-28SC1912542024-03-012025-08-28SC1912542023-02-28SC1912542023-03-012024-02-29SC1912542024-02-29SC191254ns15:Scotland2024-03-012025-08-28SC191254ns14:PoundSterling2024-03-012025-08-28SC191254ns10:Director12024-03-012025-08-28SC191254ns10:Director22024-03-012025-08-28SC191254ns10:PrivateLimitedCompanyLtd2024-03-012025-08-28SC191254ns10:SmallEntities2024-03-012025-08-28SC191254ns10:AuditExempt-NoAccountantsReport2024-03-012025-08-28SC191254ns10:SmallCompaniesRegimeForDirectorsReport2024-03-012025-08-28SC191254ns10:SmallCompaniesRegimeForAccounts2024-03-012025-08-28SC191254ns10:FullAccounts2024-03-012025-08-28SC19125412024-03-012025-08-28SC191254ns10:OrdinaryShareClass12024-03-012025-08-28SC191254ns10:CompanySecretary12024-03-012025-08-28SC191254ns10:RegisteredOffice2024-03-012025-08-28SC191254ns5:CurrentFinancialInstruments2025-08-28SC191254ns5:CurrentFinancialInstruments2024-02-29SC191254ns5:Non-currentFinancialInstruments2025-08-28SC191254ns5:Non-currentFinancialInstruments2024-02-29SC191254ns5:ShareCapital2025-08-28SC191254ns5:ShareCapital2024-02-29SC191254ns5:RevaluationReserve2025-08-28SC191254ns5:RevaluationReserve2024-02-29SC191254ns5:RetainedEarningsAccumulatedLosses2025-08-28SC191254ns5:RetainedEarningsAccumulatedLosses2024-02-29SC191254ns5:NetGoodwill2024-03-012025-08-28SC191254ns5:IntangibleAssetsOtherThanGoodwill2024-03-012025-08-28SC191254ns5:OwnedOrFreeholdAssetsns5:LandBuildings2024-03-012025-08-28SC191254ns5:PlantMachinery2024-03-012025-08-28SC191254ns5:FurnitureFittings2024-03-012025-08-28SC191254ns5:MotorVehicles2024-03-012025-08-28SC191254ns5:NetGoodwill2024-02-29SC191254ns5:NetGoodwill2025-08-28SC191254ns5:NetGoodwill2024-02-29SC191254ns5:LandBuildings2024-02-29SC191254ns5:PlantMachinery2024-02-29SC191254ns5:FurnitureFittings2024-02-29SC191254ns5:MotorVehicles2024-02-29SC191254ns5:LandBuildings2024-03-012025-08-28SC191254ns5:LandBuildings2025-08-28SC191254ns5:PlantMachinery2025-08-28SC191254ns5:FurnitureFittings2025-08-28SC191254ns5:MotorVehicles2025-08-28SC191254ns5:LandBuildings2024-02-29SC191254ns5:PlantMachinery2024-02-29SC191254ns5:FurnitureFittings2024-02-29SC191254ns5:MotorVehicles2024-02-29SC191254ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2024-02-29SC191254ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2024-03-012025-08-28SC191254ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-08-28SC191254ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2024-02-29SC191254ns5:WithinOneYearns5:CurrentFinancialInstruments2025-08-28SC191254ns5:WithinOneYearns5:CurrentFinancialInstruments2024-02-29SC191254ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-08-28SC191254ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-02-29SC191254ns5:MoreThanFiveYearsns5:Non-currentFinancialInstruments2025-08-28SC191254ns5:MoreThanFiveYearsns5:Non-currentFinancialInstruments2024-02-29SC191254ns5:Secured2025-08-28SC191254ns5:Secured2024-02-29SC191254ns5:DeferredTaxation2024-02-29SC191254ns5:DeferredTaxation2024-03-012025-08-28SC191254ns5:DeferredTaxation2025-08-28SC191254ns10:OrdinaryShareClass12025-08-28SC191254ns5:RetainedEarningsAccumulatedLosses2024-02-29SC191254ns5:RevaluationReserve2024-02-29SC191254ns5:RetainedEarningsAccumulatedLosses2024-03-012025-08-28
REGISTERED NUMBER: SC191254 (Scotland)















Unaudited Financial Statements

for the Period 1 March 2024 to 28 August 2025

for

GARDEN'S PHARMACY LIMITED

GARDEN'S PHARMACY LIMITED (REGISTERED NUMBER: SC191254)






Contents of the Financial Statements
FOR THE PERIOD 1 MARCH 2024 TO 28 AUGUST 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


GARDEN'S PHARMACY LIMITED

Company Information
FOR THE PERIOD 1 MARCH 2024 TO 28 AUGUST 2025







DIRECTORS: Mrs L M Porter
A J Porter





SECRETARY: Aberdein Considine Secretarial Services





REGISTERED OFFICE: Porter Pharmacy
Units 22 & 23 City South Park
Bankhead Drive
Portlethen
Aberdeenshire
AB12 4XX





REGISTERED NUMBER: SC191254 (Scotland)





ACCOUNTANTS: Fyfe Moir & Associates
1st Floor, 5 Abercrombie Crt
Prospect Road,
Westhill
Aberdeenshire
Grampian
AB32 6FE

GARDEN'S PHARMACY LIMITED (REGISTERED NUMBER: SC191254)

Balance Sheet
28 AUGUST 2025

28.8.25 29.2.24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 387,223 590,408
Investment property 6 - 415,399
387,223 1,005,807

CURRENT ASSETS
Stocks 7 143,915 254,159
Debtors 8 1,408,861 1,533,273
Cash at bank and in hand 187,518 2,073
1,740,294 1,789,505
CREDITORS
Amounts falling due within one year 9 875,986 705,496
NET CURRENT ASSETS 864,308 1,084,009
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,251,531

2,089,816

CREDITORS
Amounts falling due after more than one
year

10

(3,261

)

(1,047,923

)

PROVISIONS FOR LIABILITIES 12 (37,652 ) (94,421 )
NET ASSETS 1,210,618 947,472

CAPITAL AND RESERVES
Called up share capital 13 344,001 344,001
Revaluation reserve 14 200,494 70,406
Retained earnings 14 666,123 533,065
SHAREHOLDERS' FUNDS 1,210,618 947,472

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 28 August 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 28 August 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

GARDEN'S PHARMACY LIMITED (REGISTERED NUMBER: SC191254)

Balance Sheet - continued
28 AUGUST 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 August 2026 and were signed on its behalf by:




A J Porter - Director



Mrs L M Porter - Director


GARDEN'S PHARMACY LIMITED (REGISTERED NUMBER: SC191254)

Notes to the Financial Statements
FOR THE PERIOD 1 MARCH 2024 TO 28 AUGUST 2025

1. STATUTORY INFORMATION

Garden's Pharmacy Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Freehold property - 4% on cost
Plant and machinery - 20% on reducing balance
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 20% on reducing balance

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


GARDEN'S PHARMACY LIMITED (REGISTERED NUMBER: SC191254)

Notes to the Financial Statements - continued
FOR THE PERIOD 1 MARCH 2024 TO 28 AUGUST 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 32 (2024 - 34 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 March 2024
and 28 August 2025 2,065,645
AMORTISATION
At 1 March 2024
and 28 August 2025 2,065,645
NET BOOK VALUE
At 28 August 2025 -
At 29 February 2024 -

GARDEN'S PHARMACY LIMITED (REGISTERED NUMBER: SC191254)

Notes to the Financial Statements - continued
FOR THE PERIOD 1 MARCH 2024 TO 28 AUGUST 2025

5. TANGIBLE FIXED ASSETS
Fixtures
Freehold Plant and and Motor
property machinery fittings vehicles Totals
£    £    £    £    £   
COST OR VALUATION
At 1 March 2024 561,009 244,136 287,597 338,137 1,430,879
Additions - 13,779 - - 13,779
Disposals (350,927 ) - (25,314 ) (258,072 ) (634,313 )
Revaluations 24,918 - - - 24,918
At 28 August 2025 235,000 257,915 262,283 80,065 835,263
DEPRECIATION
At 1 March 2024 359,501 189,737 223,919 67,314 840,471
Charge for period 19,257 16,610 13,620 59,857 109,344
Eliminated on disposal (203,182 ) - (24,679 ) (98,338 ) (326,199 )
Revaluation adjustments (175,576 ) - - - (175,576 )
At 28 August 2025 - 206,347 212,860 28,833 448,040
NET BOOK VALUE
At 28 August 2025 235,000 51,568 49,423 51,232 387,223
At 29 February 2024 201,508 54,399 63,678 270,823 590,408

Cost or valuation at 28 August 2025 is represented by:

Fixtures
Freehold Plant and and Motor
property machinery fittings vehicles Totals
£    £    £    £    £   
Valuation in 2024 561,009 244,136 287,597 338,137 1,430,879
Valuation in 2025 (326,009 ) 13,779 (25,314 ) (258,072 ) (595,616 )
235,000 257,915 262,283 80,065 835,263

GARDEN'S PHARMACY LIMITED (REGISTERED NUMBER: SC191254)

Notes to the Financial Statements - continued
FOR THE PERIOD 1 MARCH 2024 TO 28 AUGUST 2025

5. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
COST OR VALUATION
At 1 March 2024 338,137
Disposals (258,072 )
At 28 August 2025 80,065
DEPRECIATION
At 1 March 2024 67,314
Charge for period 59,857
Eliminated on disposal (98,338 )
At 28 August 2025 28,833
NET BOOK VALUE
At 28 August 2025 51,232
At 29 February 2024 270,823

6. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 March 2024 415,399
Disposals (415,399 )
At 28 August 2025 -
NET BOOK VALUE
At 28 August 2025 -
At 29 February 2024 415,399

7. STOCKS
28.8.25 29.2.24
£    £   
Stocks 143,915 254,159

GARDEN'S PHARMACY LIMITED (REGISTERED NUMBER: SC191254)

Notes to the Financial Statements - continued
FOR THE PERIOD 1 MARCH 2024 TO 28 AUGUST 2025

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.8.25 29.2.24
£    £   
Trade debtors 275,713 518,690
Other debtors - 13,208
Inter Company A & L Porter Ltd 513,002 -
Inter Company ALPF Limited 400,150 -
Directors' current accounts - 750,211
Tax 212,186 226,455
VAT - 22,968
Prepayments 7,810 1,741
1,408,861 1,533,273

9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.8.25 29.2.24
£    £   
Bank loans and overdrafts - 116,211
Hire purchase contracts 4,891 54,701
Trade creditors 442,755 363,434
Tax 81,702 128,481
Social security and other taxes 9,412 -
VAT 4,685 -
Other creditors 1,647 2,830
Directors' current accounts 262,810 -
Accrued expenses 68,084 39,839
875,986 705,496

10. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
28.8.25 29.2.24
£    £   
Bank loans - 2-5 years - 342,550
Bank loans more 5 yr by instal - 510,389
Hire purchase contracts 3,261 194,984
3,261 1,047,923

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal - 510,389

GARDEN'S PHARMACY LIMITED (REGISTERED NUMBER: SC191254)

Notes to the Financial Statements - continued
FOR THE PERIOD 1 MARCH 2024 TO 28 AUGUST 2025

11. SECURED DEBTS

The following secured debts are included within creditors:

28.8.25 29.2.24
£    £   
Bank overdraft - 25,782
Bank loans - 943,368
Hire purchase contracts 8,152 249,685
8,152 1,218,835

Secured by standard security over all property or undertaking of the company.

12. PROVISIONS FOR LIABILITIES
28.8.25 29.2.24
£    £   
Deferred tax 37,652 94,421

Deferred
tax
£   
Balance at 1 March 2024 94,421
Provided during period (56,769 )
Balance at 28 August 2025 37,652

13. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 28.8.25 29.2.24
value: £    £   
344,001 Ordinary 1 344,001 344,001

14. RESERVES
Retained Revaluation
earnings reserve Totals
£    £    £   

At 1 March 2024 533,065 70,406 603,471
Profit for the period 133,058 133,058
Revaluation reserve Disposals - (70,406 ) (70,406 )
Revaluation - 200,494 200,494
At 28 August 2025 666,123 200,494 866,617